TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar January 10, 2003
TCL Archive Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm June 9, 1989
TCL Archive In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs April 24, 1981
